(NP (NP (NP The/DT human/JJ myelomonocytic/JJ cell/NN line/NN U-937/NN) (PP as/IN (NP (NP a/DT model/NN) (PP for/IN (S (NP-SBJ */-NONE-) (VP studying/VBG (NP (NP alterations/NNS) (PP in/IN (NP steroid-induced/JJ monokine/NN gene/NN expression/NN)))))))) :/:) (NP (NP marked/JJ enhancement/NN) (PP of/IN (NP lipopolysaccharide-stimulated/JJ interleukin-1/NN beta/NN messenger/NN RNA/NN levels/NNS)) (PP by/IN (NP 1,25-dihydroxyvitamin/NN D3/NN)) ./.))
(S (NP-SBJ (NP The/DT active/JJ metabolite/NN) (PP of/IN (NP (NP vitamin/NN D/NN) ,/, (NP (NP 1,25-dihydroxyvitamin/NN D3/NN) (PRN -LCB-/-LRB- (NP 1,25--LRB-OH-RRB-2D3/NN) -RCB-/-RRB-))))) ,/, (VP is/VBZ (NP-PRD (NP a/DT potent/JJ regulator/NN) (PP of/IN (NP human/JJ monocyte\/macrophage/JJ function/NN))) (ADVP in/FW vitro/FW)) ./.)
(S (S-ADV (NP-SBJ */-NONE-) (VP To/TO (VP establish/VB (NP (NP a/DT model/NN) (PP for/IN (NP (NP 1,25--LRB-OH-RRB-2D3/NN regulation/NN) (PP of/IN (NP human/JJ monocyte/NN monokine/NN synthesis/NN)))))))) ,/, (NP-SBJ-320 (NP three/CD human/JJ cell/NN lines/NNS) (PRN -LRB-/-LRB- (NP-COOD (NP U-937/NN) ,/, (NP THP-1/NN) ,/, and/CC (NP HL-60/NN)) -RRB-/-RRB-)) (VP were/VBD (VP examined/VBN (NP *-320/-NONE-) (PP for/IN :/: (NP-COOD (NP (LST 1/LS -RRB-/-RRB-) (NP the/DT presence/NN) (PP of/IN (NP functional/JJ 1,25--LRB-OH-RRB-2D3/NN receptors/NNS))) ;/: (NP (LST 2/LS -RRB-/-RRB-) (NP the/DT accumulation/NN) (PP of/IN (NP-COOD (NP (NP (NP interleukin-1/NN beta/NN) (PRN -LRB-/-LRB- (NP IL-1/NN beta/NN) -RRB-/-RRB-)) mRNA/NN) and/CC (NP IL-1/NN beta/NN protein/NN))) (PP in/IN response/NN to/TO (NP (NP lipopolysaccharide/NN) (PRN -LRB-/-LRB- (NP LPS/NN) -RRB-/-RRB-)))) ;/: and/CC (NP (LST 3/LS -RRB-/-RRB-) (NP the/DT regulation/NN) (PP of/IN (NP this/DT response/NN)) (PP by/IN (NP 1,25--LRB-OH-RRB-2D3/NN))))))) ./.)
(S (NP-SBJ All/DT three/CD cell/NN lines/NNS) (VP-COOD (VP expressed/VBD (NP vitamin/NN D/NN receptor/NN)) and/CC (VP had/VBD (VP increased/VBN (NP (NP levels/NNS) (PP of/IN (NP IL-1/NN beta/NN mRNA/NN))) (PP in/IN response/NN to/TO (NP LPS/NN))))) ./.)
(S (NP-SBJ (NP Preincubation/NN) (PP of/IN (NP cells/NNS)) (PP with/IN (NP 1,25--LRB-OH-RRB-2D3/NN))) (VP augmented/VBD (NP IL-1/NN beta/NN mRNA/NN levels/NNS) (PP only/RB in/IN (NP (NP-COOD (NP U-937/NN) and/CC (NP HL-60/NN)) cells/NNS))) ./.)
(S (UCP-COOD (PP From/IN (NP these/DT data/NNS)) ,/, and/CC (S-ADV (NP-SBJ */-NONE-) (VP taking/VBG (PP into/IN (NP consideration/NN)) (NP their/PRP$ (NP-COOD (NP (NP state/NN) (PP of/IN (NP differentiation/NN))) and/CC (NP (NP relative/JJ ease/NN) (PP of/IN (NP culture/NN)))))))) ,/, (NP-SBJ-323 U-937/NN) (VP was/VBD (VP chosen/VBN (NP *-323/-NONE-) (PP over/IN (NP-COOD (NP HL-60/NN) and/CC (NP THP-1/NN))) (PP as/IN (NP (NP the/DT cell/NN line/NN) (SBAR (WHNP-324 0/-NONE-) (S (NP-SBJ we/PRP) (ADVP further/RB) (VP characterized/VBD (NP *T*-324/-NONE-)))))))) ./.)
(S (PP In/IN (NP U-937/NN cells/NNS)) ,/, (NP-SBJ-325 (NP optimum/JJ (NP-COOD (NP time/NN) and/CC (NP dose/NN))) (PP of/IN (NP (NP pretreatment/NN) (PP with/IN (NP 1,25--LRB-OH-RRB-2D3/NN))))) (VP were/VBD (VP determined/VBN (S (NP-SBJ *-325/-NONE-) (VP to/TO (VP be/VB (NP-PRD (QP 12-24/CD) h/NN) (PP at/IN (NP (NP (NP a/DT receptor/NN saturating/JJ concentration/NN) (PP of/IN (NP 1,25--LRB-OH-RRB-2D3/NN))) (PRN -LRB-/-LRB- (NP 10/CD nM/NN) -RRB-/-RRB-)))))))) ./.)
(S (NP-SBJ (NP Preincubation/NN) (PP of/IN (NP cells/NNS)) (PP with/IN (NP 1,25--LRB-OH-RRB-2D3/NN))) (VP had/VBD (NP no/DT effect/NN) (PP on/IN (NP (NP the/DT time/NN course/NN) (PP of/IN (NP (NP IL-1/NN beta/NN mRNA/NN appearance/NN) (PP in/IN response/NN to/TO (NP LPS/NN))))))) ./.)
(S (ADVP However/RB) ,/, (NP-SBJ (NP exposure/NN) (PP of/IN (NP U-937/NN cells/NNS)) (PP to/TO (NP 1,25--LRB-OH-RRB-2D3/NN))) (VP-COOD (VP increased/VBD (PP by/IN (NP 200/CD %/NN)) (NP (NP the/DT level/NN) (PP of/IN (NP (NP IL-1/NN beta/NN mRNA/NN) (VP detected/VBD (NP */-NONE-)))))) and/CC (VP decreased/VBD (PP by/IN (NP (NP three/CD orders/NNS) (PP of/IN (NP magnitude/NN)))) (NP (NP the/DT concentration/NN) (PP of/IN (NP LPS/NN)) (VP required/VBN (S (NP-SBJ */-NONE-) (VP to/TO (VP achieve/VB (NP (NP steady/JJ state/NN mRNA/NN levels/NNS) (ADJP equivalent/JJ (PP to/TO (NP (NP those/DT) (VP observed/VBN (NP */-NONE-) (PP in/IN (NP (NP U-937/NN cells/NNS) (VP not/RB preincubated/VBN (NP */-NONE-) (PP with/IN (NP the/DT hormone.2+o/NN))))))))))))))))))
